Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) moved higher Wednesday, a move tied tor drugs treating head and neck cancer. Specifically the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE